EP017 · Have You Heard · Teleport Strength
Woman standing at the threshold between her physical transformation and the psychological weight it carries
Physical Results Psychological Cost
Teleport Strength · Have You Heard
June 28, 2026  ·  Episode 017

The Mental Health
Gap in the
GLP-1 Era

Clients are losing weight faster than they can find themselves.

Semaglutide. Tirzepatide. Ozempic. Wegovy. The GLP-1 revolution is rewriting the rules of weight loss — and it is moving faster than the support infrastructure around it.

As coaches, trainers, and strength professionals, we are now working with a wave of clients who are transforming their bodies at unprecedented speed. The problem? Their identity, their relationship with food, and their muscle mass are struggling to keep pace. This episode is about that gap — and what the industry is starting to do about it.

The Numbers

What's Happening in Real Time

15% Average lean mass decline when patients lose 15%+ of body weight on high-dose GLP-1
Elevated risk of major depression seen in one large 2024 study of GLP-1 users with obesity
5–10% Worsening in grip strength and functional movement measures without resistance training counterprotocols

These numbers represent real people in your sessions. They walked in lighter than last month. They look transformed. But when you cue them to load a barbell, to own their body, to feel strong — something is disconnected. The mirror tells them one story. Their nervous system is telling them another.

"Within weeks of starting a GLP-1 medicine, the constant background preoccupation with food — the mental negotiating, the anticipatory planning, the low-level demand of appetite — can go from relentless to near-absent."
— Psychology Today, June 2026

That silence is disorienting. For many clients, food was a coping mechanism, a ritual, a source of pleasure, a social anchor. When the medication quiets food noise, it doesn't replace what that noise was doing. The emotional architecture it occupied is now empty — and that vacancy shows up in your coaching conversations.

The Identity Problem

Who Are They Becoming?

Rapid body transformation is a psychological event, not just a physical one. According to health psychologist Dr. A. Janet Tomiyama of UCLA, GLP-1 medications can even be perceived as erasing a social identity — some individuals have built community, self-concept, and worldview around a larger body, and that identity does not vanish with the weight.

Clients may arrive to sessions looking like a "success story" while privately feeling like a stranger in their own skin. The reflection in the gym mirror doesn't match the internal image they've carried for decades. This is not a mindset problem. It is a developmental process — and it requires real support.

What Clients Are Presenting With

  • Dissonance between new body and old self-image
  • Loss of food as an emotional coping mechanism
  • Shame around "taking the easy way out"
  • Social friction — friends, family, diet culture pressure
  • Sudden absence of food-related rituals and structure
  • Anxiety about maintaining results after stopping medication

What the Research Is Flagging

  • Inconsistent associations with depression and suicidal ideation
  • Potential acute psychiatric effects in genetically predisposed individuals
  • Reward pathway disruption beyond just appetite
  • Eating disorder risk elevation — restriction reinforcement
  • Increased weight stigma — from self and others
  • Significant lean mass loss without structured resistance protocols

The Muscle Crisis

Losing Weight Is Not the Same as Getting Stronger

Here's where the fitness industry has a critical, non-negotiable role. GLP-1 medications do not discriminate between fat and muscle. Clinical trials and real-world data consistently show that weight reduction with GLP-1s is accompanied by a decrease in lean body mass — with older adults and those with baseline low muscle mass facing the highest risk.

Loss of skeletal muscle doesn't just change how someone looks. It worsens insulin resistance. It accelerates cardiometabolic decline. It compromises functional independence — the ability to climb stairs, carry groceries, get off the floor. A client who loses 40 pounds but sheds 6 of those pounds in muscle has made a metabolic trade they may not understand.

The Good News Trainers Need to Hear

Research presented at the European Congress on Obesity in 2025 found that adults on GLP-1 medications who combined strength training with adequate protein intake were able to retain muscle during weight loss. A May 2026 study corroborated this — over time, the majority of weight loss can be shifted toward fat, not muscle, when a proper resistance protocol is in place. Your coaching is not optional for these clients. It is the protective intervention.

The Industry Response

Integrated Mental-Physical Frameworks Are Emerging

The fitness and coaching world is beginning to respond. A new category of integrated protocols is being built specifically around GLP-1 clients — blending trauma-informed communication with strength-first programming. Here's what's being adopted by forward-thinking coaches and clinics:

01

Reframe the Goal from the First Session

Language matters. Clients on GLP-1 protocols do not need to "burn calories" — they need to build and protect muscle. Shift the entire framing of your program to strength acquisition, not energy expenditure. The scale is not the metric. Functional output is.

02

Apply Trauma-Informed Communication

Many clients arrive with a history of weight cycling, shame, and disordered food behavior. GLP-1 medications may have silenced the noise, but the trauma underneath is still there. Coaches are being trained to create psychological safety first — avoiding body comments, leading with capability, and normalizing the identity transition as part of the process.

03

Build Protein and Progressive Resistance as Non-Negotiables

Current clinical guidance recommends 1.2–1.6 grams of protein per kilogram of body mass daily for GLP-1 patients, with resistance training prescribed and tracked — not left to chance. Progressive overload, even starting from basic movement patterns, is the muscle-preservation protocol. This is your lane as a strength coach.

04

Monitor Body Composition, Not Body Weight

A client who sees their fat mass drop while lean mass holds — on a real metric printout, every 8 to 12 weeks — feels the program working and stays. A client who only watches a scale number fall, then feels weak and soft, disengages. Track what matters.

05

Build the Referral Network

Coaches are not therapists. But they are often the most consistent professional in a GLP-1 client's support ecosystem. Know which mental health professionals in your network understand the GLP-1 experience. Normalize the referral. Be the bridge.

The Teleport Strength Perspective

This Is Exactly Our Work

GLP-1 medications are not the enemy of strength culture. They are a catalyst that requires strength culture to show up more intentionally than ever before. These clients need coaches who understand that muscle is not aesthetic — it is metabolic medicine. It is mood regulation. It is independence. It is the foundation that weight loss alone can never provide.

The mental health gap in the GLP-1 era is real. The identity crisis is real. The muscle loss is real. And the opportunity to make a genuine, measurable difference in someone's life — not just their waistline — is right in front of us.

This is not a trend to observe from the sidelines. It is a gap the strength and coaching community is uniquely positioned to fill.

What's Next

Are You Ready to Coach the Whole Person?

If you work with clients on GLP-1 protocols — or you will soon — your approach needs to evolve beyond programming. Teleport Strength is building frameworks for exactly this transition.

Visit Teleport Strength
Sources Referenced in This Episode
  • APA Monitor on Psychology — "A new era of weight loss: Mental health effects of GLP-1 drugs" (July 2025)
  • Psychology Today — "Your Brain on a GLP-1: What We Know About the Mental Side" (June 2026)
  • Aspire Psychology — "Will Taking a GLP-1 Impact My Mental Health?" (March 2026)
  • Wiley / Diabetes, Obesity and Metabolism — "Psychiatric effects of GLP-1 receptor agonists: A systematic review" (2026)
  • Acta Diabetologica / Springer Nature — "Muscle loss and GLP-1R agonists use" (2026)
  • Medical News Today — "GLP-1 use may not lead to as much muscle loss as some experts feared" (May 2026)
  • Ubie Health — "Critical 2026 Update: New GLP-1 Rules to Stop Muscle Loss Now" (2026)
  • ACE Certified — "GLP-1s and Lean Mass: What the Research Shows" (June 2025)
  • MedSpa Standards — "GLP-1 and Muscle Loss 2026: Body Composition Protocols" (June 2026)
  • Medscape — "Protein, Exercise Can Curb Muscle Loss Related to GLP-1 RAs" (December 2025)